Ginkgo Results Presentation Deck

Maintaining exponentially improving technology like Knight's Law is hard, complex work... Daily Strain Tests Daily Strain Tests: MEASURING THE OUTPUT OF THE PLATFORM 10,000,000 1,000,000 100,000 10,000 1,000 100 10 Strain tests scaling 3x+/year Jan-15 COVID impact Jan-16 Jan-17 Jan-18 Jan-19 Jan-20 Jan-21 Jan-22 Key Drivers & Challenges New biological tools: New techniques can create "step change" leaps for certain types of experiments Challenge then becomes how to more broadly deploy these techniques Not all Foundry technologies scale at the same rate GenomeWeb fgen Ginkgo Bioworks to Acquire Swiss Bioengineering Firm FGen NEW YORK - Ginkgo Bioworks said on Monday that it has signed a definitive agreement to acquire FGen, a Swiss contract research organization... Automation: Focused on increasing automation across workflows as they mature Difficult to balance scalability and flexibility Miniaturization: Miniaturization not only drives down reagent usage but these techniques are often higher throughput (e.g. pipette-less liquid handling) Requires constant investment in new technologies (exponential scale tends to "break" current supply chains, often quickly - e.g. pipette tips, plates, etc.) 20 Property of Ginkgo Bioworks 2021 UPDATE & BUSINESS REVIEW

View entire presentation